An Eli Lilly & Co. Alzheimer’s drug won Food and Drug Administration approval Tuesday, capping the medication’s bumpy ride through the U.S. regulatory process and adding a second new treatment option for patients in earlier stages of the disease.
More Stories
Trump and Harris say they want to cut taxes. Here’s why you should prepare for a tax hike.
Whoever wins November’s presidential election will be faced with an immediate need to negotiate with Congress over what income-tax rates...
Finding the best 529 college-savings plan is easier than you think. Here’s what matters most.
Simplify your decision-making so you can focus on saving.
My friend inherited a $160,000 house. Will this put her Social Security disability income at risk? What can she do?
‘She really needs the money to make improvements to her house.’
‘I don’t want her to lose money’: A real-estate agent said she’d take out an ad to help me find a renter. Am I now morally obligated to use her?
“Other agents know our apartment is available for rent and now want to show it.”
Dow logs record high as stocks rise, Treasury yields jump after strong jobs data
U.S. stocks rallied Friday on fresh signs of a strong labor market, with the Dow Jones Industrial Average ending at...
How to talk to your children about money
Also: Successful approaches to beating the S&P 500’s performance, EV news and some estate-planning conundrums.